MedTrace Logo

Investigation Into Detection of Prostate Cancer Using Voided Urine (Prostate VPAC)

NCT04788277 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 675

Last updated 2026-03-13

No results posted yet for this study

Summary

The goal of this project is to detect prostate cancer cells, shed in voided urine, using the optical imaging method developed in our laboratory, which targets VPAC1 and STEAP1 receptors expressed on prostate cancer cells and validates the results with prevailing condition of the patients / volunteers.

Conditions

  • Prostate Carcinoma

Interventions

PROCEDURE

Biospecimen Collection

Undergo collection of urine samples

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Thomas Jefferson University

    lead OTHER

Principal Investigators

  • Madhukar Thakur, MD · Thomas Jefferson University

Eligibility

Min Age
50 Years
Max Age
79 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-02-26
Primary Completion
2026-07-31
Completion
2026-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04788277 on ClinicalTrials.gov